5-74685135-C-G

Variant names:

• chr5-74685135-C-G
• rs71627068
• ENST00000511181.5:c.-376-4193C>G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2 BP4_Strong

The NM_001292004.2(HEXB):​c.-376-4193C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: not found (cov: 31)
  • Exomes 𝑓: 0.0000055 (0 hom.)
  • Failed GnomAD Quality Control
• Consequence: HEXB NM_001292004.2 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.274
• Publications: 7 publications found

Genes affected

HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]

HEXB Gene-Disease associations (from GenCC):

• Sandhoff disease

  Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Myriad Women’s Health, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

ENSG00000306131 (HGNC:):

ACMG classification

Our verdict: Likely_benign. The variant received -2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.54).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001292004.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	HEXB	NM_001292004.2		c.-376-4193C>G		intron	N/A	NP_001278933.1	Q5URX0
	HEXB	NM_000521.4	MANE Select	c.-126C>G		upstream_gene	N/A	NP_000512.2	P07686

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	HEXB	ENST00000511181.5	TSL:1	c.-376-4193C>G		intron	N/A	ENSP00000426285.1	Q5URX0
	HEXB	ENST00000261416.12	TSL:1 MANE Select	c.-126C>G		upstream_gene	N/A	ENSP00000261416.7	P07686
	HEXB	ENST00000513079.5	TSL:2	n.-61C>G		upstream_gene	N/A

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000553 AC: 5 AN: 903670 Hom.: 0 Cov.: 12 AF XY: 0.00000891 AC XY: 4 AN XY: 448710

African (AFR) AF: 0.00 AC: 0 AN: 17636

American (AMR) AF: 0.00 AC: 0 AN: 12624

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 15214

East Asian (EAS) AF: 0.00 AC: 0 AN: 27570

South Asian (SAS) AF: 0.0000199 AC: 1 AN: 50316

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 29512

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 2832

European-Non Finnish (NFE) AF: 0.00000565 AC: 4 AN: 707890

Other (OTH) AF: 0.00 AC: 0 AN: 40076

GnomAD4 genome Cov.: 31

Alfa AF: 0.00 Hom.: 693

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.54
CADD	Benign	15
DANN	Benign	0.93
PhyloP100		-0.27
PromoterAI		-0.31	Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs71627068; hg19: chr5-73980960;